| 2 Outperforming Biotech Stocks to Examine on Covid-19 Vaccine Updates 11:13am / GuruFocus News - Paid Partner Content | 3 Stocks You Can Keep Forever Sep 16 / MotleyFool.com - Paid Partner Content |
| Fed's FOMC Meeting in Focus 11:11am / Zacks.com - Paid Partner Content | Why Johnson & Johnson (JNJ) is a Great Dividend Stock Right Now Sep 15 / Zacks.com - Paid Partner Content |
| Housing Data Better than Expected on Growth in Northeast 10:47am / Zacks.com - Paid Partner Content | Is AbbVie's 4.9% Dividend Yield Safe? Sep 15 / MotleyFool.com - Paid Partner Content |
| Pfizer's (PFE) COVID-19 Vaccine Successful in Children Study 10:17am / Zacks.com - Paid Partner Content | Emergent (EBS) Inks COVID-19 Manufacturing Deal With Providence Sep 15 / Zacks.com - Paid Partner Content |
| 3 Highly Profitable Low-Risk Stocks to Own 9:47am / GuruFocus News - Paid Partner Content | AzurRx (AZRX) Announces First Wave Bio Acquisition for $229M Sep 14 / Zacks.com - Paid Partner Content |
| 3 Underrated Warren Buffett Stocks That Are Smart Buys Right Now 7:25am / MotleyFool.com - Paid Partner Content | Endo (ENDP) Gains on Settlement of Opioid Cases in New York for $50M Sep 13 / Zacks.com - Paid Partner Content |
| Why Protagonist Therapeutics Stock Plunged Today Sep 20 / MotleyFool.com - Paid Partner Content | Will COVID-19 Vaccines for Children be Available by Year-End? Sep 13 / Zacks.com - Paid Partner Content |
| Big Pharma Stocks Hit Hard by Drug Price Proposals Sep 20 / GuruFocus News - Paid Partner Content | Will Pfizer's COVID Vaccine Marketing Push Pay Off? Sep 12 / MotleyFool.com - Paid Partner Content |
| Pfizer Gets a Small Boost From Vaccine Trial Announcement Sep 20 / GuruFocus News - Paid Partner Content | 3 Dividend Stocks to Buy and Hold Forever Sep 12 / MotleyFool.com - Paid Partner Content |
| FDA Panel Vetoes PFE/BNTX Third Jab for All, Vaccine Stocks Down Sep 20 / Zacks.com - Paid Partner Content | 3 Dividend Investing Tips That Could Earn You Thousands Sep 11 / MotleyFool.com - Paid Partner Content |
| Got $1,000? Here Are 2 Unstoppable Dividend Stocks to Buy Sep 19 / MotleyFool.com - Paid Partner Content | 5 of the Safest Dividend Stocks Retirees Can Buy Right Now Sep 11 / MotleyFool.com - Paid Partner Content |
| Here's Why Moderna's Stock Could Crash Before the End of 2021 Sep 19 / MotleyFool.com - Paid Partner Content | Johnson & Johnson (JNJ) Stock Moves -0.65%: What You Should Know Sep 10 / Zacks.com - Paid Partner Content |
| Moderna's Bigger Catalyst: Full FDA Approval or Booster Authorization? Sep 19 / MotleyFool.com - Paid Partner Content | Lilly's (LLY) Jardiance Gets Breakthrough Therapy Tag for HFpEF Sep 10 / Zacks.com - Paid Partner Content |
| Could This News Spark a Turnaround for Ocugen? Sep 19 / MotleyFool.com - Paid Partner Content | Decoding Mu Variant: The Next Big Threat in COVID-19 Cases? Sep 10 / Zacks.com - Paid Partner Content |
| 3 Popular Robinhood Stocks to Add to Your Portfolio This Month Sep 17 / StockNews.com - Paid Partner Content | Stock Market News for Sep 10, 2021 Sep 10 / Zacks.com - Paid Partner Content |
| Is Moderna Winning on Vaccine Efficacy? Sep 17 / MotleyFool.com - Paid Partner Content | Could This Be Pfizer's Next Blockbuster Vaccine? Sep 10 / MotleyFool.com - Paid Partner Content |
| 3 Top Warren Buffett Stocks to Buy and Hold Sep 17 / MotleyFool.com - Paid Partner Content | Why Johnson & Johnson Is a Retiree's Dream Stock Sep 10 / MotleyFool.com - Paid Partner Content |
| BlackRock Series Fund, Inc. Buys Johnson & Johnson, Qualcomm Inc, MetLife Inc, Sells Cisco ... Sep 17 / GuruFocus News - Paid Partner Content | Could This Game-Changing FDA Approval Mean Profit for Johnson & Johnson Shareholders? Sep 10 / MotleyFool.com - Paid Partner Content |
| HeartFlow: A Deep Dive Sep 16 / MotleyFool.com - Paid Partner Content | Here's the Next Blockbuster Vaccine Opportunity for Pfizer Sep 10 / MotleyFool.com - Paid Partner Content |
| Johnson & Johnson (JNJ) Stock Moves -0.12%: What You Should Know Sep 16 / Zacks.com - Paid Partner Content | Why Shares of Johnson & Johnson Are Down 2% Today Sep 09 / MotleyFool.com - Paid Partner Content |
| Why Moderna and BioNTech Topped the Market Today Sep 16 / MotleyFool.com - Paid Partner Content | This Controversial Move Could Save Johnson & Johnson Billions Sep 09 / MotleyFool.com - Paid Partner Content |
| Top Research Reports for NVIDIA, Johnson & Johnson & Toyota Sep 16 / Zacks.com - Paid Partner Content | Moderna (MRNA) Inks Deal to Develop Ultra-Rare Disease Therapy Sep 08 / Zacks.com - Paid Partner Content |
| Alzheimer's Drug for Roche Partner AC Immune Shows Promise Sep 16 / GuruFocus News - Paid Partner Content | Global trade is in disarray. It's still booming Aug 25 / CNN.com - Paid Partner Content |
| Theravance (TBPH) to Cut Workforce, Hypotension Study Fails Sep 16 / Zacks.com - Paid Partner Content | Nasdaq hits 15,000 for first time ever. Is Dow 36,000 next? Aug 24 / CNN.com - Paid Partner Content |
| Pfizer, Moderna Support COVID Vaccine Booster Before FDA Meet Sep 16 / Zacks.com - Paid Partner Content | |
+0.40 / +0.24%